Canada: Canadian Cannabis Companies Conquer U.S. Capital Markets

Legalization of cannabis for adult use in Canada was a watershed event of 2018. But a select few Canadian cannabis companies also celebrated a different milestone by breaking their way into the U.S. capital markets. The New York Stock Exchange (NYSE) and Nasdaq have embraced and now welcome listings from Canadian cannabis growers, creating new opportunities for Canadian cannabis companies to participate in the U.S. capital markets, and for U.S. investors to gain exposure to Canada's exploding cannabis industry.

A few short years ago, the idea of successfully listing a cannabis company on a U.S. stock exchange seemed next to impossible. Cannabis is, after all, still prohibited as an illegal narcotic under the Controlled Substances Act; a U.S. federal statute. This statute declares cannabis illegal along with other drugs, like heroin, that are considered to have a high potential for abuse and no accepted medical use. While adult use of cannabis for recreational purposes is now legal in 10 U.S. states, and medical use of cannabis is now legal in 33 U.S. states, the sale, cultivation and use of cannabis is still a U.S. federal crime, even in the states where it is legal. This divide between U.S. state and U.S. federal law has created a difficult environment for the multi-billion dollar U.S. cannabis industry, which remains trapped in limbo. U.S. banks, securities dealers, investors, law firms and other capital markets participants – including the major U.S. stock exchanges – have been understandably wary of any interaction with U.S. cannabis growers that could raise questions about their own compliance with U.S. federal law. These market participants quite legitimately continue to have concerns about aiding and abetting violations of the Controlled Substances Act, and concerns about money laundering through receipt of the proceeds of criminal activity, and a host of concerns about other potential sources of derivative liability.

So how did four Canadian cannabis companies manage to get listed on major U.S. stock exchanges this year? The key to understanding that, and the opportunities that exist for other Canadian cannabis companies eager to access the U.S. capital markets, is that the Controlled Substances Act only prohibits the manufacture, possession, use and distribution of prohibited substances in the United States, but not in other countries such as Canada, if those activities are conducted legally under all applicable Canadian or other federal, provincial or state laws. If the company does not manufacture, possess, use or distribute cannabis in the United States, then there is no violation of the Controlled Substances Act by the company. Nor is there a violation of any other U.S. federal law so long as the company is in compliance with the laws of Canada and every other country in which it operates. Without any violation of U.S. federal law by the company itself, there should be no reason for concern about aiding and abetting violations, or money laundering, or other potential derivative liability for U.S. capital markets participants who deal with or invest in the company or facilitate trading in its securities – including the NYSE and Nasdaq.

In July 2018, Tilray Inc. completed the first-ever IPO of a cannabis company in the United States, listing its shares on Nasdaq. Although Tilray is technically a U.S. corporation, it only handles cannabis in Canada and other countries where it is fully legal. This made it eligible to join the ranks of Nasdaq-listed companies. The initial public offering, led by Cowen in the United States and BMO Capital Markets in Canada, was widely regarded as a huge success story and vindication of the cannabis industry's rightful place in the U.S. capital markets. The IPO offering price of US$17 per share soared to a high of US$300 in September 2018 amid investor frenzy, before settling back to a respectable trading price of around US$100 per share by mid-November. Osler participated in the IPO as U.S. and Canadian legal counsel to the dealers involved, as well as in a subsequent US$475-million convertible debenture offering by Tilray.

As the growth of the cannabis industry continues in Canada, we will almost certainly see many more Canadian cannabis companies take advantage of the U.S. capital markets.

Three other Canadian cannabis companies that were already public and listed in Canada also joined the ranks of U.S. stock exchange-listed companies this year: Cronos Group, Canopy Growth and Aurora Cannabis. All three of these companies took advantage of the Canada/U.S. Multijurisdictional Disclosure System (MJDS) to register their common shares under the U.S. Securities Exchange Act of 1934 (the Exchange Act), which is a necessary step in listing on a U.S. stock exchange. For any Canadian company with at least a one-year Canadian reporting history and at least a US$75-million public float, MJDS will allow registration under the Exchange Act by filing a Form 40-F registration statement, containing past Canadian continuous disclosure documents, without the same type of review by the U.S. Securities and Exchange Commission as would normally be conducted in an IPO or other type of Exchange Act registration.

Cronos Group became the first cannabis company listed on Nasdaq in February 2018, although it has not yet conducted a registered public offering in the United States. Canopy Growth became the first cannabis company listed on NYSE in May 2018. While it has also not yet conducted a U.S. registered public offering, shortly after its listing on the NYSE Canopy Growth completed a C$600-million convertible debenture offering also led by Cowen and BMO Capital Markets, in which Osler represented the initial purchasers as both U.S. and Canadian legal counsel. Aurora Cannabis became the second cannabis company listed on the NYSE (and the fourth listed on a major U.S. stock exchange) in October 2018. Aurora Cannabis also has not yet completed a registered public offering in the United States, leaving Tilray as the first and only U.S. cannabis IPO and concurrent U.S. stock exchange listing so far.

As the growth of the cannabis industry continues in Canada, we will almost certainly see many more Canadian cannabis companies take advantage of the U.S. capital markets. U.S. investors have a keen demand for opportunities to gain exposure to the cannabis industry that do not give rise to concerns about the potential consequences of investing in a company contravening the Controlled Substances Act or other U.S. federal laws. Those cannabis companies that follow suit in 2019 and beyond will owe a debt of gratitude to the Canadian trail-blazers who conquered the U.S. capital markets this year.

For more information, read our Osler Update entitled "New cannabis licence regime and transition of existing cannabis licences" on

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions